MedPath

ABRILIA 20 MG COMPRIMIDOS EFG

ABRILIA 20 MG COMPRIMIDOS EFG

Commercialized
Register Number

85180

Prescription Type

Sin Receta

Authorization Date

Jun 16, 2020

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number85180
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BILASTINAActive
Quantity: 20 mg
Name: BILASTINA

ATC CLASSIFICATION (3)

R06A
R06AX
R06AX29

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.